NewcelX Ltd (NCEL)

• Market cap: $11.6M
• 1 day: 1.96%
• 5 days: -6.47%
• 1 month: 28.08%
• 3 months: -65.88%
• 6 months: -87.06%
• Year to date: 24.4%
• 1 year: -86.87%
• 5 years: -99.75%
• 10 years: -99.78%
• Sector: Healthcare
• Industry: Biotechnology

About: NewcelX Ltd is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company's integrated platform combines advanced stem-cell technologies and neuroscience expertise to deliver scalable, regenerative treatments targeting conditions such as Amyotrophic Lateral Sclerosis (ALS) and Type 1 Diabetes. It has research and development operations in Ness Ziona, Israel.

Employees: 11